JMN Brothers Pharma Limited Inc.

JMN Brothers Pharma Limited Inc. March 18, 2025 admin_bncm 2:45 am JMN Brothers Pharma Limited Inc. JMN Brothers Pharma Limited, Inc., a subsidiary company of Delex Pharma, was founded in the Philippines on June 27, 2016, by the management heading the latter organization. Although it is a new player in the market, it has slowly made rounds to become one of the trusted companies in the country, focusing on women’s health and ethical products.  While JMN Pharma strives to bring premier and affordable pharmaceutical products to the Philippine market, it has forged partnerships with credible WHO-GMP-compliant local and multinational manufacturing companies. Hence, it boosts the highest ethical standard of the company in the pharmaceutical field. Moreover, the various Intensive Care Unit (ICU) medicines, multivitamin, and food supplement it markets are duly licensed by the Philippine Food and Drug Administration (FDA). These assure the utmost safety of the market.  Latest Post 18 Mar 2025 JMN Brothers Pharma Limited Inc. 18 Mar 2025 Delex Pharma International Inc. 18 Mar 2025 DLX Holdings Corp. Popular Categories Strategic Partnerships Regulatory Approvals and Certifications Post-Merger Developments Mergers and Acquisitions Financial Performance Expansion Plans Community Engagement and Outreach OUR SUBSIDIARIES Current Operational Subsidiaries DLX Holdings Corp. DLX Holdings Corp., (DLX) the subsidiary of our company, was registered in December 2012, and is the parent company of Delex Pharma International Inc. (DPI). DLX is engaged in the development, distribution and trading of medical supplies, equipment, pharmaceutical products, and food supplements. Read More Delex Pharma International Inc. Delex Pharma International, Inc. (DPI), a socially accountable Filipino-owned and ISO 9001:2015-certified company, has continuously served its nationwide market for fourteen years. The company is 60% owned by DLX Holdings, Inc. and 40% owned by High Everest Capital Inc. rEAD mORE JMN Brothers Pharma Limited Inc. JMN Brothers Pharma Limited, Inc., a subsidiary company of Delex Pharma, was founded in the Philippines on June 27, 2016, by the management heading the latter organization. Although it is a new player in the market, it has slowly made rounds to become one of the trusted companies in the country, focusing on women’s health and ethical products. Read More

Delex Pharma International Inc.

Delex Pharma International Inc. admin_bncm Delex Pharma International Inc. Delex Pharma International, Inc. (DPI), a socially accountable Filipino-owned and ISO 9001:2015-certified company, has continuously served its nationwide market for fourteen years. The company is 60% owned by DLX Holdings, Inc. and 40% owned by High Everest Capital Inc. The profound ideas of venturing into the pharmaceutical industry from its competent award-winning leaders commenced on July 13, 2009. They continued to expand, establishing more businesses in medical devices and retail pharmacy (with three branches). DPI offers cost-effective and quality ICU drugs and medical devices manufactured by GMP-certified multinational companies (list and copy of agreements included in the index). It distributes and promotes various products in the critical care, anesthesia, medical devices, and oncology fields, housed in its government-compliant warehouses with a total lot area of 1,224 square meters. Meanwhile, as the company strives for excellence in meeting the gaps in critical care, it has gained the trust of its clients in the hospital channels, drug chains, and diagnostic laboratories.Furthermore, DPI continues to nurture its almost two hundred (200) employees. Latest Post 18 Mar 2025 JMN Brothers Pharma Limited Inc. 18 Mar 2025 Delex Pharma International Inc. 18 Mar 2025 DLX Holdings Corp. Popular Categories Strategic Partnerships Regulatory Approvals and Certifications Post-Merger Developments Mergers and Acquisitions Financial Performance Expansion Plans Community Engagement and Outreach OUR SUBSIDIARIES Current Operational Subsidiaries DLX Holdings Corp. DLX Holdings Corp., (DLX) the subsidiary of our company, was registered in December 2012, and is the parent company of Delex Pharma International Inc. (DPI). DLX is engaged in the development, distribution and trading of medical supplies, equipment, pharmaceutical products, and food supplements. Read More Delex Pharma International Inc. Delex Pharma International, Inc. (DPI), a socially accountable Filipino-owned and ISO 9001:2015-certified company, has continuously served its nationwide market for fourteen years. The company is 60% owned by DLX Holdings, Inc. and 40% owned by High Everest Capital Inc. rEAD mORE JMN Brothers Pharma Limited Inc. JMN Brothers Pharma Limited, Inc., a subsidiary company of Delex Pharma, was founded in the Philippines on June 27, 2016, by the management heading the latter organization. Although it is a new player in the market, it has slowly made rounds to become one of the trusted companies in the country, focusing on women’s health and ethical products. Read More

DLX Holdings Corp.

DLX Holdings Corp. admin_bncm DLX Holdings Corp. DLX Holdings Corp., (DLX) the subsidiary of our company, was registered in December 2012, and is the parent company of Delex Pharma International Inc. (DPI). DLX is engaged in the development, distribution and trading of medical supplies, equipment, pharmaceutical products, and food supplements. DLX is a Philippine based pharmaceutical company ranking 3rd in the hospital channel with a growth rate of 12.2% and ranked 49th in the Philippine pharmaceutical industry based on the IQVIA Mat Ref Dec 2020 Report. Share this : Latest Post 18 Mar 2025 JMN Brothers Pharma Limited Inc. 18 Mar 2025 Delex Pharma International Inc. 18 Mar 2025 DLX Holdings Corp. Popular Categories Strategic Partnerships Regulatory Approvals and Certifications Post-Merger Developments Mergers and Acquisitions Financial Performance Expansion Plans Community Engagement and Outreach OUR SUBSIDIARIES Current Operational Subsidiaries DLX Holdings Corp. DLX Holdings Corp., (DLX) the subsidiary of our company, was registered in December 2012, and is the parent company of Delex Pharma International Inc. (DPI). DLX is engaged in the development, distribution and trading of medical supplies, equipment, pharmaceutical products, and food supplements. Read More Delex Pharma International Inc. Delex Pharma International, Inc. (DPI), a socially accountable Filipino-owned and ISO 9001:2015-certified company, has continuously served its nationwide market for fourteen years. The company is 60% owned by DLX Holdings, Inc. and 40% owned by High Everest Capital Inc. rEAD mORE JMN Brothers Pharma Limited Inc. JMN Brothers Pharma Limited, Inc., a subsidiary company of Delex Pharma, was founded in the Philippines on June 27, 2016, by the management heading the latter organization. Although it is a new player in the market, it has slowly made rounds to become one of the trusted companies in the country, focusing on women’s health and ethical products. Read More